Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
66.12%
80%
—
—
20%
—
5 Years
Score—
Net Growth66.12%
Net Trend80%
Net Income Consistency—
Rev Growth—
Rev Trend20%
Revenue Consistency—
Black Diamond Therapeutics Inc fundamental performance
Across Black Diamond Therapeutics Inc's full reported history, from 2020 to 2025, revenue grew from $ 0.00 to $ 70M and net income went from -$ 67M to $ 22M. Revenue increased in 17% of the years measured; net income in 67%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.10 | — |
1 Year2025-08-12 | $ 2.54 | -17.32% |
5 Years2021-08-12 | $ 9.70 | -78.35% |
All Time2020-01-30 | $ 39.48 | -94.68% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-01-30 |
|---|---|---|---|---|
| Price | $ 2.10 | $ 2.54 | $ 9.70 | $ 39.48 |
| Return | — | -17.32% | -78.35% | -94.68% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 42M | $ 110M |
| 2025 | $ 70M | $ 22M | $ 128M |
| 2024 | $ 0.00 | -$ 69M | $ 98M |
| 2023 | $ 0.00 | -$ 82M | $ 131M |
| 2022 | $ 0.00 | -$ 91M | $ 122M |
| 2021 | $ 0.00 | -$ 125M | $ 209M |
| IPO2020 | $ 0.00 | -$ 67M | $ 315M |
Explore beyond BDTX
You're looking at Black Diamond Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
